Brendan James Kilbane, MD
Brendan J. Kilbane, MD, is an emergency medicine physician in the Division of Pediatric Emergency Medicine at University Hospitals Rainbow Babies & Children's Hospital and Assistant Professor, Pediatrics, Case Western Reserve University School of Medicine.
Dr. Kilbane is board certified in pediatrics and pediatric emergency medicine and is certified in advanced trauma life support, pediatric advanced life support and advanced cardiac life support. His special interests are pediatric emergency medicine and urgent care.
He completed his undergraduate studies at the University of Notre Dame, South Bend, Ind., and earned his medical degree from Wright State University School of Medicine, Dayton, Ohio. He completed a pediatrics residency at Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, and a fellowship in pediatric emergency medicine at Children's Memorial Hospital, Chicago, Ill. Dr. Kilbane was appointed to the UH Rainbow Babies & Children’s Hospital staff in 2007.
Dr. Kilbane has authored or coauthored scientific papers and abstracts in leading medical journals. He speaks at regional, national and international medical meetings about pediatric emergency care and urgent care. He is a Fellow of the American Academy of Pediatrics and a member of the Irish American Paediatric Society and Alpha Omega Alpha Medical Honor Society.
Honors and Recognition
Fellow, American Academy of Pediatrics
Alpha Omega Alpha Honor Medical r Society
Quality improvement and patient safety
- Pediatric Emergency Medicine
Patient Satisfaction Reviews
0 out of 5
- Pediatric Emergency Medicine - American Board of Emergency Medicine
- Pediatrics - American Board of Pediatrics
Fellowship | Pediatric Emergency Medicine
Pediatric Emergency Medicine - Children's Memorial Hospital (2004 - 2007)
Residency | Pediatrics
Pediatrics - Cincinnati Children's Hospital Medical Center (2001 - 2004)
Wright State University Boonshoft School Of Medicine (2001)
University Of Notre Dame (1995)
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Brendan James Kilbane did not disclose any Outside Relationships with Industry.